Catalyst Wire Dossier Catalyst Wire Dossier

Talsaclidine (Free Base)

talsaclidine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Talsaclidine (Free Base), covering 2014-09-26 to 2014-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type [Phase 2]

See pricing